1-3 of 3
Birgit Michels
Close
Sort by
Journal Articles

Third-Generation Chimeric Antigen Receptor (CAR) T Cells in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin Lymphoma (NHL) - Results from the Heidelberg Trial 1 (HD-CAR-1 trial)

Maria-Luisa Schubert, Anita Schmitt, Brigitte Neuber, Angela Hückelhoven-Krauss, Alexander Kunz, Lei Wang, Birgit Michels, Philip Waldhoff, Leopold Sellner, Felix Korell, Susanne Hofmann, Petra Pavel, Anthony D Ho, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt
Journal: Blood
Blood (2021) 138 (Supplement 1): 1734.
https://doi.org/10.1182/blood-2021-152028
Published: 2021
Journal Articles

Third-Generation CAR T Cells Targeting CD19 Are Associated with an Excellent Safety Profile and Might Improve Persistence of CAR T Cells in Treated Patients

Maria-Luisa Schubert, MD, Anita Schmitt, MD, Brigitte Neuber, Angela Hückelhoven-Krauss, Alexander Kunz, Lei Wang, MD, Ulrike Gern, Birgit Michels, Leopold Sellner, MD, Susanne Hofmann, MD, Carsten Müller-Tidow, MD, Peter Dreger, Michael Schmitt, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 51.
https://doi.org/10.1182/blood-2019-125423
Published: 2019
Journal Articles

Peptide Vaccination Against Cytomegalovirus (CMV) Elicits Immunological and Clinical Responses after Allogeneic Stem Cell Transplantation Even from a CMV Seronegative Donor

Michael Schmitt, MD, Anita Schmitt, MD, Markus Wiesneth, Angela Hückelhoven, PhD, Zeguang Wu, Juergen Kuball, MD, Lei Wang, Peter Schauwecker, MD, Susanne Hofmann, Marlies Götz, Birgit Michels, Birgit Maccari, Patrick Wuchter, MD, Thomas Mertens, MD, Paul Schnitzler, MD, Hartmut Döhner, MD, Anthony D. Ho, MD, Donald Bunjes, Peter Dreger, MD, Hubert Schrezenmeier, MD, Jochen Greiner
Journal: Blood
Blood (2016) 128 (22): 2519.
https://doi.org/10.1182/blood.V128.22.2519.2519
Published: 2016